Stock Market & Financial Investment News

Charles River Labs has reached attractive entry point, says Sterne AgeeSterne Agee continues to believe that Charles River should generate high incremental margins and disproportionate growth in earnings relative to its sales growth. The firm keeps a $71 price target and Buy rating on the shares.